Have multiple conditions? Click here

New Clinical Trials for Vaccines

The subject matter for vaccine clinical research is almost endless. There are so many diseases and chronic ailments that it would be wonderful to have a vaccine for all of them. Unfortunately that’s not realistic. Costs are a prohibitive factor in the study, development and widespread use of a vaccine. There are ongoing vaccine clinical studies to test those that might be good possibilities. Please review the list of current vaccine clinical trials and let us know if you think you qualify.
 

What are Vaccines?

Vaccines are biological preparations that can help build immunity to diseases when given in small amounts. The way a vaccine works is that the body’s immune system attacks the foreign body found in the vaccine. The next time that body shows up the immune system “remembers” it and knows how to deal with it. There are two types of vaccines – prophylactic which prevent, and therapeutic which is used against things like cancer. Vaccines were first recognized and studied in the 1770s with smallpox. Vaccines are usually made up of dead versions of a disease, although in some cases living versions are used. There is some controversy surrounding vaccine treatments. Some groups believe that they do not work.
 

Vaccine Treatments

Sometimes the immune system simply does not respond to vaccines. With the development of many different vaccines children these days are on a complicated schedule of vaccines shots and booster shots starting once their immune systems have fully developed. Mild forms of the disease may develop after a vaccine treatment. A needle is the most common method of giving vaccines, but new methods for administering them are being developed. These include pills, patches and inhalers. An example of a successful vaccine treatment is the measles. In 1958 there were 763,094 cases. In 2008, after a measles vaccine was developed, there were only 54 cases.

Have multiple conditions? Click here

Showing 1-100 of 118
There are 118 Vaccines Clinical Trials
Name City State Zip
Vaccines Clinical Trial Birmingham AL 35216
Vaccines Clinical Trial Birmingham AL 35216
Vaccines Clinical Trial DeLand FL 32720
Vaccines Clinical Trial DeLand FL 32720
Vaccines Clinical Trial DeLand FL 32720
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia Mobile AL 36617
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease Alabaster AL 35007
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Glendale AZ 85304
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Glendale AZ 85304
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Fayetteville AR 72703
Permission to Collect Blood Over Time for Research Stanford CA 94305
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers Stanford CA 94305
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users - 1 San Francisco CA 94143
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia La Mesa CA 91942
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Anaheim CA 92807
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Anaheim CA 92807
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects Anaheim CA 92807
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Aurora CO 80010
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Aurora CO 80010
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US New Haven CT 06519
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants New Haven CT 06519
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years New Haven CT 06519
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects New Haven CT 06519
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years New Haven CT 06519
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination Newark DE 19713
Vaccinia Vaccine (ACAM2000) for the Production of Vaccinia Immune Globulin Intravenous(VIGIV) Altamonte Springs FL 32701
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Roswell GA 30076
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Roswell GA 30076
Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females Jonesboro GA 30236
Immune Responses to Yellow Fever Vaccine Decatur GA 30030
Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females Atlanta GA 30303
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Honolulu HI 96813
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Honolulu HI 96813
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Boise ID 83712
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Boise ID 83712
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Boise ID 83712
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia Chicago IL 60611
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Ames IA 50010
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Westwood KA 66205
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Westwood KA 66205
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Westwood KA 66205
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Louisville KY 40202
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Louisville KY 40202
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease Ashland KY 41101
Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEcâ„¢) Fort Detrick MD 21702
Immune Responses to Smallpox Vaccination Bethesda MD 20892
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer Bethesda MD 20892
Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine Bethesda MD 20892
A Phase I Trial of Safety and Immunogenicity of Gardasil(Registered Trademark) Vaccination Post Stem Cell Transplantation in Patients With and Without Immunosuppression Bethesda MD 20892
Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors Baltimore MD 21201
Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil Baltimore MD 21201
Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil Baltimore MD 21201
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Boston MA 02114
Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine Boston MA 02114
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease Boston MA 02114
Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Boston MA 02114
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Boston MA 02114
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Boston MA 02114
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Grand Rapids MI 49546
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia Detroit MI 48202
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Chesterfield MO 63017
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Chesterfield MO 63017
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Grand Island NE 68803
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Grand Island NE 68803
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Las Vegas NV 89102
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Las Vegas NV 89102
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Cherry Hill NJ 08003
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Cherry Hill NJ 08003
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Albuquerque NM 87109
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects Albuquerque NM 87109
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years New York NY 10032
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years New York NY 10032
Text Message Reminder-Recalls For Early Childhood Vaccination New York NY 10032
Real-time Influenza Vaccine Surveillance New York NY 10032
Giving Immunizations Through Vaccine Education Brooklyn NY 11203
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting Durham NC
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia Akron OH 44304
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Weatherford OK 73096
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Weatherford OK 73096
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Klamath Falls OR 97601
Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting Pittsburgh PA 15261
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Philadelphia PA 19104
Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States Philadelphia PA 19104
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Philadelphia PA 19104
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Philadelphia PA 19104
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Philadelphia PA 19104
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Philadelphia PA 19104
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia Allentown PA 18104
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Charleston SC 29425
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Charleston SC 29425
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Charleston SC 29425
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Charleston SC 29425
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Charleston SC 29425
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years Charleston SC 29425
Cell Mediated Immunity in Older Adults Nashville TN 37232
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease Bristol TN 37620
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia San Antonio TX 78284
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US Austin TX 78705
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants Austin TX 78705
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years Austin TX 78705

Showing 1-100 of 118
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register